The video CMMIT: Bringing Science Closer to Patients outlines the exciting collaboration between Murdoch University and The Perron Institute. The opening comments by Steve Wilton outlines the vision for extending the success in DMD to as many other diseases around the world as possible.
Whats all this got to do with Phylogica? The answer to that question may be instrumental for the future direction of Phylogica and its focus upon antisense oligonucleotides. Think complementarity of expertise in Phylogica's delivery platform and the Institutes ASO capability and clinical expertise in disease targets of interest.
The story of Phylogica is changing. The big picture is changing. Once we were looking for small targets in a crowded space. Its entirely possible that we are now looking for an ASO platform which could redefine treatments for genetic diseases. Can a drug cure genetic diseases? We may be about to find out particularly with a program in reach of the clinic by the end of the year. It doesn't mean risk is less but the reward part of the equation has gone off the charts.
PYC Price at posting:
2.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)